Omega-3 fatty acids
Idiopathic Pulmonary Fibrosis
Clinical trials
2
Developer
Oslo University Hospital
Overview
Omega-3 fatty acids is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 2 tracked IPF clinical trials.
Omega-3 fatty acids clinical trials
Explore related
Medical disclaimer. This page summarizes research about Omega-3 fatty acids for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.